Breathomics for assessing the effects of treatment and withdrawal with inhaled beclomethasone/formoterol in patients with COPD

Montuschi, Paolo; Santini, Giuseppe; Mores, Nadia; Vignoli, Alessia; Macagno, Francesco; Shoreh, Rugia; Tenori, Leonardo; Zini, Gina; Fuso, Leonello; Mondino, Chiara; Di Natale, Corrado; D&apos; Luchinat, Claudio; Barnes, Peter J.; Higenbottam, Tim

doi:10.3389/fphar.2018.00258

Breathomics for assessing the effects of treatment and withdrawal with inhaled beclomethasone/formoterol in patients with COPD

By Paolo Montuschi, Giuseppe Santini, Nadia Mores, Alessia Vignoli, Francesco Macagno, Rugia Shoreh, Leonardo Tenori, Gina Zini, Leonello Fuso, Chiara Mondino, Corrado Di Natale, D&apos, Claudio Luchinat, Peter J. Barnes and Tim Higenbottam

Get PDF (2 MB)

Topics: Breathomics; COPD; Inhaled corticosteroids; Long-acting ß2-agonists; Pharmacotherapy; Pharmacology; Pharmacology (medical)

Publisher: 'Frontiers Media SA'

Year: 2018

DOI identifier: 10.3389/fphar.2018.00258

OAI identifier: oai:flore.unifi.it:2158/1131417

Provided by: Florence Research

Downloaded from https://flore.unifi.it/bitstream/2158/1131417/2/fphar-09-00258.pdf

Breathomics for assessing the effects of treatment and withdrawal with inhaled beclomethasone/formoterol in patients with COPD

Suggested articles